A new method for precise botulinum toxin injections to treat chronic pelvic pain
An Novel Medical System for Quantitative Diagnosis and Personalized Precision Botulinum Neurotoxin Injection in Chronic Pelvic Pain Management
This study is testing a new way to give botulinum injections to help women with chronic pelvic pain, aiming to make the injections more accurate so they can feel better and have fewer side effects.
Quick facts
| Grant type | Sbir 2 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Hillmed INC NIH-funded |
| Lab location | 1 site (Katy, United States) |
| Project ID | NIH-11139696 on NIH RePORTER |
What this research studies
This research focuses on developing a novel medical system that enhances the precision of botulinum neurotoxin (BoNT) injections for managing chronic pelvic pain, particularly in women suffering from interstitial cystitis/bladder pain syndrome. The approach aims to improve the accuracy of injections by targeting neuromuscular junctions more effectively, which could lead to better pain relief and fewer side effects. By utilizing advanced technology, the study seeks to optimize treatment outcomes for patients who have not responded well to conventional therapies. The research will involve testing this new injection technique to assess its efficacy and safety in a clinical setting.
Who could benefit from this research
Good fit: Ideal candidates for this research are women experiencing chronic pelvic pain, particularly those diagnosed with interstitial cystitis or bladder pain syndrome.
Not a fit: Patients who do not have chronic pelvic pain or those whose pain is not related to pelvic floor overactivity may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a more effective and safer treatment option for women suffering from chronic pelvic pain.
How similar studies have performed: Previous studies have shown promise in using botulinum toxin for similar conditions, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
Katy, United States
- Hillmed INC — Katy, United States (Active)
Researchers
- Principal investigator: Dias, Nicholas — Hillmed INC
- Study coordinator: Dias, Nicholas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.